Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04399941 · ClinicalTrials.gov registry record · NA

Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis

A NA study of End Stage Renal Disease, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT04399941 is a NA study of End Stage Renal Disease that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 50 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04399941, a NA study of End Stage Renal Disease, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central venous stenosis (CVS) and affects number of patients on hemodialysis in the United States and can compromise the dialysis efficacy. The current diagnostic modality for CVS is venography, which has several limitations. This study proposes to examine intravenous ultrasound (IVUS) as a potentially superior modality, which will provide additional information.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Venography
  • DIAGNOSTIC_TEST Intravascular ultrasound (IVUS)
  • OTHER Image processing

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2021-08-03
Est. Completion 2026-09
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT04399941

The ClinicalTrials.gov registry entry for NCT04399941 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (94% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 3 interventions - of which Venography is the first listed.

NCT04399941 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04399941 about?

NCT04399941 is a clinical study titled "Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis". Hemodialysis represents a life line of patients with end stage renal disease, who are commonly maintained on hemodialysis through catheters. Prolonged exposure to these catheters eventually damages the walls of veins, which results in stenosis at the local site. This condition is called central veno...

What is the current status of trial NCT04399941?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-08-03. Estimated completion is 2026-09.

What conditions does trial NCT04399941 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT04399941?

The interventions under investigation include: Venography (DIAGNOSTIC_TEST), Intravascular ultrasound (IVUS) (DIAGNOSTIC_TEST), Image processing (OTHER).

Who is sponsoring clinical trial NCT04399941?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04399941 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.